← Eichor
Study identifier: NCT06789458 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Pro-Resolution Mediator Levels in Periodontitis Stage III and IV Before and After Periodontal Therapy

Condition: Peridontal Disease  ·  Sponsor: Cairo University

PhaseNA
Planned participants22
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to assess Pro-Resolution Mediator levels during non-surgical periodontal therapy in individuals with Stage III and IV periodontitis, comparing them to healthy subjects. Periodontitis, a chronic inflammatory condition affecting tooth-supporting tissues, can lead to tooth loss and systemic complications. Understanding the role of pro-resolving lipid mediators in inflammation resolution may offer insights into therapeutic benefits associated with these mediators.

This description comes directly from the study's public registry record.

Talk to the study team

Husam Ghazi Alharbi, Master Degree  ·  +201222284055  ·  husam.ghazi@dentistry.cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (2)

Faculty of Dentistry-Cairo UniversityManial, Cairo Governorate, EgyptRecruiting
faculty of dentistry Cairo universityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06789458